1. Home
  2. NEOG vs HRMY Comparison

NEOG vs HRMY Comparison

Compare NEOG & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neogen Corporation

NEOG

Neogen Corporation

HOLD

Current Price

$11.64

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$38.95

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEOG
HRMY
Founded
1981
2017
Country
United States
United States
Employees
N/A
293
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.2B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
NEOG
HRMY
Price
$11.64
$38.95
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$10.67
$44.11
AVG Volume (30 Days)
2.2M
709.9K
Earning Date
04-09-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
99.20
7.97
EPS
N/A
1.84
Revenue
$870,400,000.00
$868,453,000.00
Revenue This Year
N/A
$19.75
Revenue Next Year
N/A
$12.88
P/E Ratio
N/A
$20.92
Revenue Growth
N/A
21.51
52 Week Low
$4.90
$25.52
52 Week High
$12.85
$40.87

Technical Indicators

Market Signals
Indicator
NEOG
HRMY
Relative Strength Index (RSI) 56.74 56.20
Support Level $8.86 $34.87
Resistance Level $12.85 $39.40
Average True Range (ATR) 0.39 1.08
MACD -0.06 -0.11
Stochastic Oscillator 42.34 47.38

Price Performance

Historical Comparison
NEOG
HRMY

About NEOG Neogen Corporation

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: